Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/12396
Title: Novel drug delivery system of eugenol against inflammation and periodontal infections
Researcher: Pramod K
Guide(s): Ali, Javed
Ansari, S H
Keywords: Drug delivery systems
Novel drug delivery systems
Controlled drug delivery
Eugenol
Nanoemulsion
Emulsion
Nanoparticles
Diclofenac emulgel
Upload Date: 30-Oct-2013
University: Jamia Hamdard University
Completed Date: 2012
Abstract: The present study aims to develop and evaluate novel drug delivery systems of eugenol against inflammation and periodontal infections. Two drug delivery systems have been investigated (i) the development of a nanoemulsion gel topical drug delivery system of eugenol for its anti-inflammatory activity and its pharmacodynamic evaluation; (ii) the formulation of a nanoparticulate drug delivery system of eugenol for periodontal disease. The researcher has concluded that whereas the performance of the developed eugenol nanoemulsion gels are found to be promising for the treatment of inflammation, the eugenol-loaded polycaprolactone nanoparticles could serve as a novel colloidal drug delivery system for the treatment of periodontal infections.
Pagination: 280p.
URI: http://hdl.handle.net/10603/12396
Appears in Departments:Department of Pharmaceutics

Files in This Item:
File Description SizeFormat 
01_title.pdf45.83 kBAdobe PDFView/Open
02_certificate.pdf30.2 kBAdobe PDFView/Open
03_acknowledgement.pdfAttached File54.42 kBAdobe PDFView/Open
04_contents.pdf25.67 kBAdobe PDFView/Open
05_list of tables.pdf17.75 kBAdobe PDFView/Open
06_list of figures.pdf24.48 kBAdobe PDFView/Open
07_chapter 1.pdf352.66 kBAdobe PDFView/Open
08_chapter 2.pdf288.64 kBAdobe PDFView/Open
09_chapter 3.pdf149.79 kBAdobe PDFView/Open
10_chapter 4.pdf268.24 kBAdobe PDFView/Open
11_chapter 5.pdf15.53 MBAdobe PDFView/Open
12_chapter 6.pdf41.19 kBAdobe PDFView/Open
13_chapter 7.pdf216.08 kBAdobe PDFView/Open
14_appendix.pdf21.94 kBAdobe PDFView/Open


Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.